7WMX

Crystal structure of methylenetetrahydrofolate reductase MSMEG_6649 from Mycobacterium smegmatis with 5,10-methylenetetrahydrofolate

7WMX の概要

• エントリーDOI: 10.2210/pdb7wmx/pdb
• 分子名称: Methylenetetrahydrofolate reductase (2 entities in total)
• 機能のキーワード: methylenetetrahydrofolate reductase, transferase
• 由来する生物種: Mycolicibacterium smegmatis MC2 155
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 32978.76

構造登録者

Lin, W.,Wang, W. (登録日: 2022-01-17, 公開日: 2023-01-25, 最終更新日: 2024-05-29)

主引用文献

Li, J.,Yang, M.,Li, W.,Lu, C.,Feng, D.,Shang, Z.,Wang, C.,Lin, W.
Structural and functional characterization of a mycobacterial methylenetetrahydrofolate reductase utilizing NADH as the exclusive cofactor.
Biochem.J., 480:1129-1146, 2023

PubMed Abstract: 5,10-Methylenetetraydrofolate reductase (MTHFR) is a key enzyme in folate metabolism. MSMEG_6649, a non-canonical MTHFR from Mycobacterium smegmatis, was previously reported as a monomeric protein lacking the flavin coenzyme. However, the structural basis for its unique flavin-independent catalytic mechanism remains poorly understood. Here, we determined the crystal structures of apo MTHFR MSMEG_6649 and its complex with NADH from M. smegmatis. Structural analysis revealed that the groove formed by the loops 4 and 5 of non-canonical MSMEG_6649 interacting with FAD was significantly larger than that of canonical MTHFR. Meanwhile, the NADH-binding site in MSMEG_6649 is highly similar to the FAD binding site in canonical MTHFR, suggesting that NADH plays the same role (immediate hydride donor for methylenetetraydrofolate) as FAD in the catalytic reaction. Using biochemical analysis, molecular modeling, and site-directed mutagenesis, the critical residues participating in the binding of NADH and the substrate 5,10-methylenetetrahydrofolate as well as the product 5-methyltetrahydrofolate were identified and validated. Taken together, this work not only provides a good starting point for understanding the potential catalytic mechanism for MSMEG_6649, but also identifies an exploitable target for the development of anti-mycobacterial drugs.

PubMed: 37435857
DOI: 10.1042/BCJ20230138

実験手法

X-RAY DIFFRACTION (2.264 Å)